Cargando…
Recent Advances in Immune Therapies for Gastric Cancer
Gastric cancer (GC) is an aggressive malignancy that is the third leading cause of cancer mortality worldwide. Localized GC can be cured with surgery, but most patients present with more advanced non-operable disease. Until recently, treatment options for relapsed and refractory advanced GC have bee...
Autores principales: | Olnes, Matthew J., Martinson, Holly A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417143/ https://www.ncbi.nlm.nih.gov/pubmed/33664460 http://dx.doi.org/10.1038/s41417-021-00310-y |
Ejemplares similares
-
Gastric cancer in Alaska Native people: A cancer health disparity
por: Martinson, Holly A, et al.
Publicado: (2018) -
Molecular Classification of Gastric Cancer among Alaska Native People
por: Martinson, Holly A., et al.
Publicado: (2020) -
Immune Therapies for Hematologic Malignancies
por: Olnes, Matthew J.
Publicado: (2021) -
Immune Therapies for Myelodysplastic Syndromes and Acute Myeloid Leukemia
por: Kapoor, Sargam, et al.
Publicado: (2021) -
Recent advances in gastric cancer
por: Al Dulaimi, David
Publicado: (2014)